Health
[Written Question] Breast Cancer: Drugs
Key Points
Question by: Lord Kamall Answering Body: Department of Health and Social Care Question: To ask His Majesty's Government what progress has been made regarding talks taking place between AstraZeneca, Daiichi Sankyo, NHS England and NICE about the HER2-low metastatic breast cancer treatment Enhertu.
Question by: Lord Kamall
Answering Body: Department of Health and Social Care
Question: To ask His Majesty's Government what progress has been made regarding talks taking place between AstraZeneca, Daiichi Sankyo, NHS England and NICE about the HER2-low metastatic breast cancer treatment Enhertu.